Coney Island Hospital is a public teaching hospital located in the Coney Island neighborhood of Brooklyn, New York City. It is owned by NYC Health + Hospitals, a public benefit corporation of the city.

There are 371 beds in Coney Island Hospital.

During the past decade, Coney Island Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 12 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 9 clinical trials were completed. i.e. 450% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Coney Island Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 6 trials, followed by "Coney Island Hospital, Brooklyn, NY" with 2 trials sponsored, "NYU Langone Health" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored and "Boehringer Ingelheim" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Coney Island Hospital" #1 collaborator was "Cancer and Leukemia Group B" with 3 trials as a collaborator, "National Cancer Institute (NCI)" with 3 trials as a collaborator, "North Central Cancer Treatment Group" with 3 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "Coney Island Hospital" are "Breast Cancer" (3 trials), "Stage IIA Breast Cancer AJCC v6 and v7" (3 trials), "Stage IIB Breast Cancer AJCC v6 and v7" (3 trials), "Breast Adenocarcinoma" (2 trials) and "Coronary Artery Disease" (2 trials). Many other conditions were trialed in "Coney Island Hospital" in a lesser frequency.

Most popular intervention types in "Coney Island Hospital" are "Drug" (15 trials), "Other" (12 trials), "Biological" (6 trials), "Behavioral" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (7 trials), "Bevacizumab" (5 trials), "Paclitaxel" (5 trials), "Cyclophosphamide" (3 trials) and "Doxorubicin Hydrochloride" (3 trials). Other intervention names were less common.

The vast majority of trials in "Coney Island Hospital" are 16 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Coney Island Hospital". undefined are not yet recruiting, undefined are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Coney Island Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Coney Island Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".